• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Marksans Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3285.0
  • ISIN : INE750C01026
224.86 -3 (-1.14%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    220.23

  • Today’s High

    227.28

  • Open

    227.28

  • Perv Close

    227.45

  • 52W Low

    171.00

  • 52W High

    358.70

Key Indicators

  • P/E(TTM)

    54.25

  • Mar.Cap (₹Cr.)

    10,189.84

  • Div & Yield %

    0.36

  • Book Value(₹)

    30.53

  • Debt-Equity Ratio

    -1.14

  • AGM Date

    01-Aug-2025

  • EPS

    4.14

  • P/E Ratio

    54.25

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    10,189.84

  • RONW (%)

    16.53

  • ROCE (%)

    20.78

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    30.50

  • Sales( ₹ in Cr.)

    1,174.37

  • NP (in Cr.)

    187.76

  • NP Var(%)

    40.0

  • Div%

    80.0

  • CPS (₹)

    4.80

  • EPS (₹)

    4.10

  • Traded Value (₹ in Lakhs)

    10,178.06

  • 52 Week High

    358.70

  • 52 Week Low

    171.00

  • Price BSE

    225.0

  • Price NSE

    225.00

  • Market Capital( in Cr.)

    10,178.06

  • P/C Ratio

    46.90

  • P/E Ratio

    54.30

  • Price Vs.BV

    4.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,174.37 853.27 655.20 658.29 599.55 433.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,174.37 853.27 655.20 658.29 599.55 433.42
Other Income 69.83 62.07 60.48 42.25 31.16 0.17
Stock Adjustments -0.70 7.25 10.19 -3.89 -0.55 5.63
Total Income 1,243.50 922.59 725.87 696.65 630.16 439.22
EXPENDITURE :            
Raw Materials 639.24 486.18 404.64 373.70 337.36 251.04
Power and Fuel Cost 30.73 26.04 14.24 11.49 10.90 8.68
Employee Cost 101.68 77.19 56.09 60.46 54.64 48.51
Other Manufacturing Expenses 64.62 46.10 21.09 5.25 6.98 4.76
Selling and Administration Expenses 112.99 73.19 61.54 67.57 60.08 43.86
Miscellaneous Expenses 20.37 11.88 15.89 22.22 15.31 10.70
Employee Benefit Expenses 101.68 77.19 56.09 60.46 54.64 48.51
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 969.63 720.58 573.49 540.68 485.28 367.55
Operating Profit 273.88 202.01 152.38 155.97 144.87 71.66
Interest 1.17 0.99 3.61 3.80 5.35 7.29
Gross Profit 272.71 201.02 148.77 152.17 139.52 64.37
Depreciation 29.45 29.13 16.74 17.66 15.19 11.64
Profit Before Tax 243.26 171.89 132.03 134.51 124.33 52.73
Current Tax 52.14 37.46 29.34 30.02 28.19 11.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.84 0.68 -0.17 0.50 -2.24 3.68
Reported Net Profit 188.27 133.76 102.87 103.99 98.38 37.90
Extraordinary Items 0.51 0.07 -0.05 0.00 0.03 0.03
Adjusted Net Profit 187.76 133.69 102.92 103.99 98.35 37.87
Adjustment below Net Profit -0.30 0.28 -8.64 0.05 -0.20 -0.39
P & L Balance brought forward 345.00 233.61 155.21 61.41 -32.69 -62.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 27.19 22.66 15.82 10.23 4.09 7.47
P & L Balance carried down 505.78 345.00 233.61 155.21 61.41 -32.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 80.00 60.00 50.00 25.00 25.00 10.00
Dividend Per Share(Rs) 0.80 0.60 0.50 0.25 0.25 0.10
Earnings Per Share-Unit Curr 4.15 2.95 2.27 2.54 2.40 0.93
Earnings Per Share(Adj)-Unit Curr 4.15 2.95 2.27 2.54 2.40 0.93
Book Value 30.53 26.98 24.52 16.90 14.65 12.35
Book Value(Adj)-Unit Curr 30.53 26.98 24.52 16.90 14.65 12.35

Shareholding Pattern

  • Promoter Group

    43.87%

  • Public Share Holding

    56.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 198,822,009 43.87 198,822,009 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 198,822,009 43.87 198,822,009 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 39,050,881 8.62 39,050,881 1
Financial Institutions / Banks 2,911 0.00 911 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 51,038,939 11.26 51,038,939 136
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 16,073,842 3.55 16,073,842 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 8,838,068 1.95 8,838,068 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 115,004,641 25.38 115,002,641 159
2] Non Institution
Bodies Corporate 7,548,295 1.67 7,547,295 991
Clearing Members 191,008 0.04 191,008 35
Directors of their Relatives 0 0.00 0 0
Employees 4,265 0.00 4,265 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,045,264 1.33 6,045,264 4,267
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,342,479 0.74 3,342,479 2,632
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 16,831,304 3.71 16,831,304 29
Individuals holding nominal share capital up to Rs. 1 lakh 104,375,145 23.03 104,111,325 248,089
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 166,447 0.04 166,447 8
Others 827,790 0.18 827,790 1
Sub Total 139,337,096 30.75 139,072,276 256,060
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 453,163,746 100.00 452,896,926 256,221

Company Background

Marksans Pharma LtdPharmaceuticals - Indian - Formulations

  • Marksans Pharma Ltd
  • BSE Code : 3285.0
  • ISIN : INE750C01026

  • Incorporation Year

    1992

  • Registered Office

    11th Flr GRANDEUR Oshiwara
    Veera Desai Extn Rd Andheri(W), Mumbai,
    Maharashtra-400053

  • Telephone

    91-22-40012000

  • FAX

    91-22-40012011

  • Chairman

    Mark Saldanha

  • Managing Director

    Mark Saldanha

  • Company Secretary

    Harshavardhan Panigrahi

  • Auditor

    MSKA & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Marksans Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Marksans Pharma 224.60 1,244.21 1,174.37 54.12 18.55
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10